AKT1 and breast cancer: In EL4 cells, the treatment with 100 μg/ml of LMW HA significantly increased the expression of p-Akt vs. BC (*p < 0.05), whereas the treatment with DOX (0.5 μM and 1 μM) induced no differences in p-Akt levels (Figure 4B).